Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Markus Meyerhöfer"'
Autor:
Viral Shah, George Giotopoulos, Hikari Osaki, Markus Meyerhöfer, Eshwar Meduri, Benedict Schubert, Haiyang Yun, Sarah J Horton, Shuchi Agrawal-Singh, Patricia S Haehnel, Faisal Basheer, Dave Lugo, Michael WM Kühn, Borhane Guezguez, Matthias Theobald, Thomas Kindler, Paolo Gallipoli, Rab K Prinjha, Brian JP Huntly, Daniel Sasca
Initial clinical trials with drugs targeting epigenetic modulators - such as bromodomain and extraterminal (BET) inhibitors - demonstrate modest results in acute myeloid leukemia (AML). The main reason for this involves an increased transcriptional p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99d2692ba4e1ae6a1d89938b2c1a17d9
https://doi.org/10.1101/2022.09.14.507850
https://doi.org/10.1101/2022.09.14.507850
Autor:
Lisa Spiecker, Daniel Sasca, Andrea Schüler, Piyush More, Ines Witte, Victoria Petermann, Markus Meyerhöfer, Julia Mehlig, Viral N. Shah, Nina Cabezas-Wallscheid, Thomas Kindler, Andreas Daiber, Sven Horke, Andrea Pautz, Hartmut Kleinert, Patricia S. Haehnel
Publikováno v:
Oxidative medicine and cellular longevity
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity
Background. Long-term hematopoietic stem cells (LT-HSCs) reside in bone marrow niches with tightly controlled reactive oxygen species (ROS) levels. ROS increase results into LT-HSC differentiation and stem cell exhaustion. Paraoxonase 2 (PON2) has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbe25f2205b615c3bfa97ab916451dd6
https://doi.org/10.1155/2021/3917028
https://doi.org/10.1155/2021/3917028
